Social Cognition Clinical Trial
— TASITOfficial title:
The German Version of the Awareness of Social Inference Test: Development of a Short and Sensitive Version for Use in Clinical Populations
Verified date | August 2020 |
Source | University Hospital, Basel, Switzerland |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Goal of the current project is the development of a German-language test battery for a realistic investigation of core areas of social issues Cognition (emotion, perspective taking). This test battery should be used in the investigation of patients with neuropsychological disorders. Investigators plan to establish a German-version of the TASIT that is more sensitive and shorter in administration than the original TASIT.
Status | Completed |
Enrollment | 240 |
Est. completion date | March 31, 2020 |
Est. primary completion date | March 31, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 35 Years and older |
Eligibility |
Inclusion Criteria: - from the age of 35, - at least 7 years of education - understand German or Swiss German - Subjective statement of good health - Signed consent Exclusion Criteria: - Montreal Cognitive Assessment (MoCA) value below the fifth percentile of subjectively cognitive healthy persons - signs of depressive mood (Geriatric Depression Scale (GDS) score = 5 points or Beck Depression Inventory (BDI) = 10 points) - Severe sensory deficits with potentially negative influence test results - Severe motor deficits with potentially negative influence test results - Systemic diseases or brain diseases with potentially negative Influence on test results - St. n. Traumatic brain injury (with unconsciousness of at least 30 minutes) - Severe pain with potentially negative influence on the test results - Psychiatric problems like alcohol dependence syndrome or Schizophrenia according to Diagnostic and Statistical Manual (DSM)®-5 - Regular use of drugs with potentially negative Influence on the test results with the exception of taking Benzodiazepines at night - general anesthesia less than 3 months ago |
Country | Name | City | State |
---|---|---|---|
Switzerland | University Hospital | Basel |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Basel, Switzerland |
Switzerland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Accuracy rate in emotion perception and perception of beliefs and intentions | The proportion of top scorers for any question - i.e. the proportion of participants who reach the full score of a specific scene. This proportion will be estimated for each scene and intensity separately with 95% confidence interval. | 60 minutes | |
Primary | Accuracy rate in perception of beliefs | The proportion of top scorers for any question - i.e. the proportion of participants who reach the full score of a specific scene. This proportion will be estimated for each scene and intensity separately with 95% confidence interval. | 60 minutes | |
Primary | Accuracy rate in perception of intentions | The proportion of top scorers for any question - i.e. the proportion of participants who reach the full score of a specific scene. This proportion will be estimated for each scene and intensity separately with 95% confidence interval. | 60 minutes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04406675 -
Social Cognition in Patients With Amyotrophic Lateral Sclerosis
|
N/A | |
Completed |
NCT02566356 -
Adult Study Oxytocin - fMRI
|
Early Phase 1 | |
Active, not recruiting |
NCT00747396 -
The Bucharest Early Intervention Project
|
N/A | |
Completed |
NCT02228031 -
Oxytocin, Emotions and Mirror Neurons
|
Early Phase 1 | |
Completed |
NCT02567032 -
Adult Study Oxytocin - Behavioral
|
Early Phase 1 | |
Recruiting |
NCT03035669 -
Effects of Mindfulness Training on Emotion Regulation and Social Cognition.
|
N/A | |
Completed |
NCT03775564 -
Effectiveness of the RemedRugby Program
|
N/A | |
Not yet recruiting |
NCT06213194 -
The Effects of Executive Functions and Social Cognition on Mental Health
|
N/A | |
Recruiting |
NCT05773872 -
Evaluation of Social Cognition in Patient With Type 1 or Type 2 Narcolepsy Versus Patients With Idiopathic Hypersomnia
|
N/A | |
Completed |
NCT05320991 -
Effects of Ketamine on Mentalizing and Metacognition in Healthy Volunteers
|
Phase 4 | |
Recruiting |
NCT01903915 -
Social Dysfunction and Brain Dysfunction in Patients With Schizophrenia
|
N/A | |
Recruiting |
NCT05194254 -
MRI-Eye Tracking Pairing, a Tool for Assessing Social Cognition in Children With ASD
|
N/A | |
Completed |
NCT00884897 -
Oxytocin and Social Cognition in Schizophrenia
|
Phase 2 | |
Not yet recruiting |
NCT03812913 -
Neuropsychological Assessment of Children and Adolescents With Turner Syndrome
|
||
Completed |
NCT02568709 -
Oxytocin MEG Study
|
Early Phase 1 | |
Completed |
NCT02652013 -
Evaluation and Neural Basis of Communication in Patients With Multiple Sclerosis
|
N/A | |
Completed |
NCT05866328 -
Online TP (Training Program) on SC (Social Cognition) for Schizophrenia
|
N/A | |
Completed |
NCT01616407 -
Effects of MDMA and Methylphenidate on Social Cognition
|
Early Phase 1 | |
Completed |
NCT01206842 -
Social Cognition Training in Schizophrenia
|
N/A | |
Completed |
NCT02577575 -
Adult Oxytocin Study
|
Early Phase 1 |